| Field | Row 1 |
|---|---|
| adsh | 0001628280-25-023925 |
| cik | 1680378 |
| name | SENESTECH, INC. |
| sic | 2870 |
| countryba | US |
| stprba | AZ |
| cityba | PHOENIX |
| zipba | 85027 |
| bas1 | 777 W. PINNACLE PEAK ROAD |
| bas2 | SUITE B104 |
| baph | (928) 779 - 4143 |
| countryma | US |
| stprma | AZ |
| cityma | FLAGSTAFF |
| zipma | 86003 |
| mas1 | PO BOX 3627 |
| mas2 | |
| countryinc | US |
| stprinc | DE |
| ein | 202079805 |
| former | |
| changed | |
| afs | 4-NON |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250508 |
| accepted | 2025-05-08 17:21:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | snes-20250331_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001628280-25-023925 | 20241231 | Accounts Payable Current | 215000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Additional Paid In Capital | 140652000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Assets Current | 3164000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20241231 | Cash And Cash Equivalents At Carrying Value | 1307000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -1833000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20241231 | Common Stock Shares Authorized | 100000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20240331 | Earnings Per Share Diluted | -3.5600 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20240331 | Gross Profit | 135000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Increase Decrease In Accounts Receivable | 163000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Increase Decrease In Contract With Customer Liability | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Increase Decrease In Other Operating Assets | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Inventory Net | 753000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Investment Income Net | 3000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Liabilities | 734000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20240331 | Net Cash Provided By Used In Operating Activities | -1829000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20241231 | Notes Payable Current | 56000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20241231 | Preferred Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250430 | Proceeds From Issuance Of Common Stock | 2000000.0000 | USD | 0 | us-gaap/2024 | Plan Name= A T M Financing; Subsequent Event Type= Subsequent Event; | ||
| 0001628280-25-023925 | 20240331 | Proceeds From Repayments Of Notes Payable | -8000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Share Based Compensation | 91000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Assets | 3626000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 1655000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Increase Decrease In Accrued Liabilities | 32000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Interest Paid Net | 5000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20240331 | Investment Income Net | 15000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Net Cash Provided By Used In Operating Activities | -1557000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20240331 | Operating Expenses | 1978000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20241231 | Other Assets Noncurrent | 58000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20241231 | Preferred Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Preferred Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Prepaid Expense Current | 258000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Proceeds From Issuance Of Common Stock | 1066000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Retained Earnings Accumulated Deficit | -137762000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20231231 | Stockholders Equity | -129913000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001628280-25-023925 | 20240331 | Stockholders Equity | -131745000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001628280-25-023925 | 20250331 | Stockholders Equity | 2000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001628280-25-023925 | 20250331 | Accounts Payable Current | 164000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Accrued Liabilities Current | 310000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20241231 | Assets | 3278000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20241231 | Common Stock Shares Issued | 1035893.0000 | shares | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Comprehensive Income Net Of Tax | -1665000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20241231 | Contract With Customer Liability Current | 12000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Depreciation And Amortization | 39000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20240331 | Income Taxes Paid | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Increase Decrease In Inventories | -41000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20240331 | Increase Decrease In Prepaid Expense | -42000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20241231 | Liabilities | 767000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20241231 | Liabilities Current | 561000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20240331 | Net Cash Provided By Used In Financing Activities | -2000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Net Cash Provided By Used In Financing Activities | 1941000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20240331 | Nonoperating Income Expense | 11000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Nonoperating Income Expense | -2000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20240331 | Payments To Acquire Property Plant And Equipment | 2000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20241231 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20241231 | Prepaid Expense Current | 377000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20241231 | Retained Earnings Accumulated Deficit | -136097000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 485000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20231231 | Stockholders Equity | 1000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001628280-25-023925 | 20240331 | Stockholders Equity | 136354000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001628280-25-023925 | 20241231 | Stockholders Equity | 138607000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001628280-25-023925 | 20241231 | Stockholders Equity | 1000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001628280-25-023925 | 20241231 | Accrued Liabilities Current | 278000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 1307000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20241231 | Common Stock Shares Outstanding | 1035893.0000 | shares | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20240331 | Cost Of Goods And Services Sold | 280000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Earnings Per Share Basic | -1.2800 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20240331 | General And Administrative Expense | 1608000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20240331 | Increase Decrease In Accounts Payable | -34000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Increase Decrease In Accounts Payable | -51000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20240331 | Interest Expense Debt | 4000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20240331 | Net Cash Provided By Used In Investing Activities | -2000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Net Cash Provided By Used In Investing Activities | -36000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20240331 | Net Income Loss | -1832000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Net Income Loss | -1665000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001628280-25-023925 | 20250331 | Operating Income Loss | -1663000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Other Assets Noncurrent | 58000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20241231 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Proceeds From Repayments Of Notes Payable | -14000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20240331 | Proceeds From Warrant Exercises | 6000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20231231 | Stockholders Equity | 136263000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001628280-25-023925 | 20241231 | Stockholders Equity | 2511000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Stockholders Equity | 140652000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001628280-25-023925 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 5395000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20241231 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0001628280-25-023925 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Gross Profit | 313000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20240331 | Increase Decrease In Accounts Receivable | 66000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20240331 | Increase Decrease In Accrued Liabilities | 23000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20241231 | Inventory Net | 794000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Notes Payable Current | 57000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Proceeds From Warrant Exercises | 889000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Research And Development Expense | 418000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Stockholders Equity | 2892000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 1299971.0000 | shares | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | 348000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Common Stock Shares Outstanding | 1775930.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001628280-25-023925 | 20250331 | Common Stock Value | 2000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Cost Of Goods And Services Sold | 172000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20240331 | Depreciation And Amortization | 37000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20240331 | Increase Decrease In Contract With Customer Liability | -3000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20240331 | Increase Decrease In Other Operating Assets | 2000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Liabilities And Stockholders Equity | 3626000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20241231 | Long Term Notes Payable | 206000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Long Term Notes Payable | 191000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Net Income Loss | -1665000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Preferred Stock Shares Authorized | 10000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20231231 | Stockholders Equity | 6351000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20240331 | Stockholders Equity | 4610000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20240331 | Stockholders Equity | 1000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001628280-25-023925 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 514453.0000 | shares | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 1299971.0000 | shares | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20241231 | Accounts Receivable Net Current | 335000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20241231 | Assets Current | 2813000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Cash And Cash Equivalents At Carrying Value | 1655000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 3562000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0001628280-25-023925 | 20250331 | Common Stock Shares Authorized | 100000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20231231 | Common Stock Shares Outstanding | 514003.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001628280-25-023925 | 20240331 | Common Stock Shares Outstanding | 514463.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001628280-25-023925 | 20241231 | Common Stock Shares Outstanding | 1035893.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001628280-25-023925 | 20240331 | Comprehensive Income Net Of Tax | -1832000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Liabilities Current | 543000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20240331 | Operating Income Loss | -1843000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20240331 | Proceeds From Issuance Of Common Stock | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20241231 | Property Plant And Equipment Net | 335000.0000 | USD | 0 | us-gaap/2024 | Property Plant And Equipment By Type= Depreciable Property Plant And Equipment; | ||
| 0001628280-25-023925 | 20250331 | Property Plant And Equipment Net | 404000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 514453.0000 | shares | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Accounts Receivable Net Current | 498000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20241231 | Additional Paid In Capital | 138607000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Common Stock Shares Issued | 1775930.0000 | shares | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Common Stock Shares Outstanding | 1775930.0000 | shares | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20241231 | Common Stock Value | 1000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Contract With Customer Liability Current | 12000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20240331 | Earnings Per Share Basic | -3.5600 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Earnings Per Share Diluted | -1.2800 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | General And Administrative Expense | 1558000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Income Taxes Paid | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20240331 | Increase Decrease In Inventories | 79000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Increase Decrease In Prepaid Expense | -119000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Interest Expense Debt | 5000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20240331 | Interest Paid Net | 4000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20241231 | Liabilities And Stockholders Equity | 3278000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20240331 | Net Income Loss | -1832000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001628280-25-023925 | 20250331 | Operating Expenses | 1976000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Payments To Acquire Property Plant And Equipment | 36000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Preferred Stock Par Or Stated Value Per Share | 0.0010 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20241231 | Preferred Stock Shares Authorized | 10000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20241231 | Property Plant And Equipment Net | 407000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20250331 | Property Plant And Equipment Net | 296000.0000 | USD | 0 | us-gaap/2024 | Property Plant And Equipment By Type= Depreciable Property Plant And Equipment; | ||
| 0001628280-25-023925 | 20240331 | Research And Development Expense | 370000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 415000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20240331 | Share Based Compensation | 85000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001628280-25-023925 | 20241231 | Stockholders Equity | -136097000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001628280-25-023925 | 20250331 | Stockholders Equity | -137762000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Increase Decrease In Accounts Receivable | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Accounts Receivable | The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services. |
| Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Revenue From Contract With Customer Excluding Assessed Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Revenue from Contract with Customer, Excluding Assessed Tax | Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. |
| Depreciation And Amortization | us-gaap/2024 | 0 | 0 | monetary | D | D | Depreciation, Depletion and Amortization, Nonproduction | The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. |
| Payments To Acquire Property Plant And Equipment | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Property, Plant, and Equipment | The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. |
| Comprehensive Income Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. |
| Increase Decrease In Contract With Customer Liability | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Contract with Customer, Liability | Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable. |
| Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Accounts Receivable Net Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Accounts Receivable, after Allowance for Credit Loss, Current | Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. |
| Additional Paid In Capital | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
| Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Long Term Notes Payable | us-gaap/2024 | 0 | 0 | monetary | I | C | Notes Payable, Noncurrent | Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion. |
| Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Prepaid Expense Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Expense, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. |
| Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Cost Of Goods And Services Sold | us-gaap/2024 | 0 | 0 | monetary | D | D | Cost of Goods and Services Sold | The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. |
| Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Gross Profit | us-gaap/2024 | 0 | 0 | monetary | D | C | Gross Profit | Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. |
| Income Taxes Paid | us-gaap/2024 | 0 | 0 | monetary | D | C | Income Taxes Paid | Amount, before refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax. |
| Increase Decrease In Prepaid Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense | The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods. |
| Other Assets Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Other Assets, Noncurrent | Amount of noncurrent assets classified as other. |
| Accrued Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accrued Liabilities, Current | Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Increase Decrease In Other Operating Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Other Operating Assets | Amount of increase (decrease) in operating assets classified as other. |
| Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Preferred Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Issued | Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt. | |
| Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
| Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
| Increase Decrease In Inventories | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Inventories | The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities. |
| Interest Expense Debt | us-gaap/2024 | 0 | 0 | monetary | D | D | Interest Expense, Debt | Amount of the cost of borrowed funds accounted for as interest expense for debt. |
| Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Nonoperating Income (Expense) | The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). |
| Preferred Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Preferred Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Proceeds From Repayments Of Notes Payable | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from (Repayments of) Notes Payable | Amount of cash inflow (outflow) from long-term debt supported by a written promise to pay an obligation. |
| Accounts Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
| Notes Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Notes Payable, Current | Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer. |
| Operating Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
| Operating Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
| Inventory Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Inventory, Net | Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. |
| Research And Development Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Research and Development Expense | Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Commitments And Contingencies | us-gaap/2024 | 0 | 0 | monetary | I | C | Commitments and Contingencies | Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. |
| Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Increase Decrease In Accounts Payable | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable | The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. |
| Interest Paid Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Interest Paid, Excluding Capitalized Interest, Operating Activities | Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount. |
| Investment Income Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Investment Income, Net | Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
| Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Preferred Stock, Par or Stated Value Per Share | Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. | |
| Proceeds From Warrant Exercises | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Warrant Exercises | The cash inflow associated with the amount received from holders exercising their stock warrants. |
| Contract With Customer Liability Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Contract with Customer, Liability, Current | Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current. |
| Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Net Cash Provided By Used In Investing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. |
| Preferred Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | |
| Preferred Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Outstanding | Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. | |
| Proceeds From Issuance Of Common Stock | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Issuance of Common Stock | The cash inflow from the additional capital contribution to the entity. |
| Increase Decrease In Accrued Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accrued Liabilities | The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid. |
| Property Plant And Equipment Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001628280-25-023925 | 2 | 3 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
| 0001628280-25-023925 | 2 | 4 | BS | 0 | H | Accounts Receivable Net Current | us-gaap/2024 | Accounts receivable, net | 0 |
| 0001628280-25-023925 | 2 | 5 | BS | 0 | H | Prepaid Expense Current | us-gaap/2024 | Prepaid expenses and other current assets | 0 |
| 0001628280-25-023925 | 2 | 6 | BS | 0 | H | Inventory Net | us-gaap/2024 | Inventory, net | 0 |
| 0001628280-25-023925 | 2 | 7 | BS | 0 | H | Assets Current | us-gaap/2024 | Total current assets | 0 |
| 0001628280-25-023925 | 2 | 8 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2024 | Property and equipment, net | 0 |
| 0001628280-25-023925 | 2 | 9 | BS | 0 | H | Other Assets Noncurrent | us-gaap/2024 | Other noncurrent assets | 0 |
| 0001628280-25-023925 | 2 | 10 | BS | 0 | H | Assets | us-gaap/2024 | Total assets | 0 |
| 0001628280-25-023925 | 2 | 13 | BS | 0 | H | Accounts Payable Current | us-gaap/2024 | Accounts payable | 0 |
| 0001628280-25-023925 | 2 | 14 | BS | 0 | H | Accrued Liabilities Current | us-gaap/2024 | Accrued expenses | 0 |
| 0001628280-25-023925 | 2 | 15 | BS | 0 | H | Notes Payable Current | us-gaap/2024 | Current portion of notes payable | 0 |
| 0001628280-25-023925 | 2 | 16 | BS | 0 | H | Contract With Customer Liability Current | us-gaap/2024 | Deferred revenue | 0 |
| 0001628280-25-023925 | 2 | 17 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total current liabilities | 0 |
| 0001628280-25-023925 | 2 | 18 | BS | 0 | H | Long Term Notes Payable | us-gaap/2024 | Notes payable, less current portion | 0 |
| 0001628280-25-023925 | 2 | 19 | BS | 0 | H | Liabilities | us-gaap/2024 | Total liabilities | 0 |
| 0001628280-25-023925 | 2 | 20 | BS | 0 | H | Commitments And Contingencies | us-gaap/2024 | Commitments and contingencies (see notes) | 0 |
| 0001628280-25-023925 | 2 | 22 | BS | 0 | H | Preferred Stock Value | us-gaap/2024 | Preferred stock, $0.001 par value, 10,000,000 shares authorized, none issued and outstanding | 0 |
| 0001628280-25-023925 | 2 | 23 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common stock, $0.001 par value, 100,000,000 shares authorized, 1,775,930 and 1,035,893 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively | 0 |
| 0001628280-25-023925 | 2 | 24 | BS | 0 | H | Additional Paid In Capital | us-gaap/2024 | Additional paid-in capital | 0 |
| 0001628280-25-023925 | 2 | 25 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
| 0001628280-25-023925 | 2 | 26 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total stockholders equity | 0 |
| 0001628280-25-023925 | 2 | 27 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | Total liabilities and stockholders equity | 0 |
| 0001628280-25-023925 | 3 | 1 | BS | 1 | H | Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | Preferred stock, par value (in dollars per share) | 0 |
| 0001628280-25-023925 | 3 | 2 | BS | 1 | H | Preferred Stock Shares Authorized | us-gaap/2024 | Preferred stock, shares authorized (in shares) | 0 |
| 0001628280-25-023925 | 3 | 3 | BS | 1 | H | Preferred Stock Shares Issued | us-gaap/2024 | Preferred stock, shares issued (in shares) | 0 |
| 0001628280-25-023925 | 3 | 4 | BS | 1 | H | Preferred Stock Shares Outstanding | us-gaap/2024 | Preferred stock, shares outstanding (in shares) | 0 |
| 0001628280-25-023925 | 3 | 5 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common stock, par value (in dollars per share) | 0 |
| 0001628280-25-023925 | 3 | 6 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common stock, shares authorized (in shares) | 0 |
| 0001628280-25-023925 | 3 | 7 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock, shares issued (in shares) | 0 |
| 0001628280-25-023925 | 3 | 8 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common stock, shares outstanding (in shares) | 0 |
| 0001628280-25-023925 | 4 | 1 | IS | 0 | H | Revenue From Contract With Customer Excluding Assessed Tax | us-gaap/2024 | Revenues, net | 0 |
| 0001628280-25-023925 | 4 | 2 | IS | 0 | H | Cost Of Goods And Services Sold | us-gaap/2024 | Cost of sales | 0 |
| 0001628280-25-023925 | 4 | 3 | IS | 0 | H | Gross Profit | us-gaap/2024 | Gross profit | 0 |
| 0001628280-25-023925 | 4 | 5 | IS | 0 | H | Research And Development Expense | us-gaap/2024 | Research and development | 0 |
| 0001628280-25-023925 | 4 | 6 | IS | 0 | H | General And Administrative Expense | us-gaap/2024 | Selling, general and administrative | 0 |
| 0001628280-25-023925 | 4 | 7 | IS | 0 | H | Operating Expenses | us-gaap/2024 | Total operating expenses | 0 |
| 0001628280-25-023925 | 4 | 8 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | Loss from operations | 0 |
| 0001628280-25-023925 | 4 | 10 | IS | 0 | H | Investment Income Net | us-gaap/2024 | Interest income | 0 |
| 0001628280-25-023925 | 4 | 11 | IS | 0 | H | Interest Expense Debt | us-gaap/2024 | Interest expense | 1 |
| 0001628280-25-023925 | 4 | 12 | IS | 0 | H | Nonoperating Income Expense | us-gaap/2024 | Other income (expense), net | 0 |
| 0001628280-25-023925 | 4 | 13 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001628280-25-023925 | 4 | 14 | IS | 0 | H | Comprehensive Income Net Of Tax | us-gaap/2024 | Comprehensive loss | 0 |
| 0001628280-25-023925 | 4 | 15 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Weighted average shares outstanding - basic (in shares) | 0 |
| 0001628280-25-023925 | 4 | 16 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Weighted average shares outstanding - diluted (in shares) | 0 |
| 0001628280-25-023925 | 4 | 17 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Net loss per share - basic (in dollars per share) | 0 |
| 0001628280-25-023925 | 4 | 18 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Net loss per share - diluted (in dollars per share) | 0 |
| 0001628280-25-023925 | 5 | 2 | CF | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001628280-25-023925 | 5 | 4 | CF | 0 | H | Depreciation And Amortization | us-gaap/2024 | Depreciation and amortization | 0 |
| 0001628280-25-023925 | 5 | 5 | CF | 0 | H | Share Based Compensation | us-gaap/2024 | Stock-based compensation | 0 |
| 0001628280-25-023925 | 5 | 7 | CF | 0 | H | Increase Decrease In Accounts Receivable | us-gaap/2024 | Accounts receivable | 1 |
| 0001628280-25-023925 | 5 | 8 | CF | 0 | H | Increase Decrease In Prepaid Expense | us-gaap/2024 | Prepaid expenses and other current assets | 1 |
| 0001628280-25-023925 | 5 | 9 | CF | 0 | H | Increase Decrease In Inventories | us-gaap/2024 | Inventory | 1 |
| 0001628280-25-023925 | 5 | 10 | CF | 0 | H | Increase Decrease In Other Operating Assets | us-gaap/2024 | Other assets | 1 |
| 0001628280-25-023925 | 5 | 11 | CF | 0 | H | Increase Decrease In Accounts Payable | us-gaap/2024 | Accounts payable | 0 |
| 0001628280-25-023925 | 5 | 12 | CF | 0 | H | Increase Decrease In Accrued Liabilities | us-gaap/2024 | Accrued expenses | 0 |
| 0001628280-25-023925 | 5 | 13 | CF | 0 | H | Increase Decrease In Contract With Customer Liability | us-gaap/2024 | Deferred revenue | 0 |
| 0001628280-25-023925 | 5 | 14 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash used in operating activities | 0 |
| 0001628280-25-023925 | 5 | 16 | CF | 0 | H | Payments To Acquire Property Plant And Equipment | us-gaap/2024 | Purchase of property and equipment | 1 |
| 0001628280-25-023925 | 5 | 17 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2024 | Net cash used in investing activities | 0 |
| 0001628280-25-023925 | 5 | 19 | CF | 0 | H | Proceeds From Warrant Exercises | us-gaap/2024 | Proceeds from the exercise of warrants, net | 0 |
| 0001628280-25-023925 | 5 | 20 | CF | 0 | H | Proceeds From Issuance Of Common Stock | us-gaap/2024 | Proceeds from issuances of common stock, net | 0 |
| 0001628280-25-023925 | 5 | 21 | CF | 0 | H | Proceeds From Repayments Of Notes Payable | us-gaap/2024 | Repayments of notes payable | 0 |
| 0001628280-25-023925 | 5 | 22 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Net cash provided by (used in) financing activities | 0 |
| 0001628280-25-023925 | 5 | 23 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | Increase (decrease) in cash and cash equivalents | 0 |
| 0001628280-25-023925 | 5 | 24 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash and cash equivalents, beginning of period | 0 |
| 0001628280-25-023925 | 5 | 25 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash and cash equivalents, end of period | 0 |
| 0001628280-25-023925 | 5 | 27 | CF | 0 | H | Interest Paid Net | us-gaap/2024 | Interest paid | 0 |
| 0001628280-25-023925 | 5 | 28 | CF | 0 | H | Income Taxes Paid | us-gaap/2024 | Income taxes paid | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |